Skip to main content
. 2022 Nov 14;23(22):14058. doi: 10.3390/ijms232214058

Figure 1.

Figure 1

Potential use of curcumin to mitigate therapy-related side effects in mCRC. CURC: curcumin; NF-κB: nuclear factor kappa B; Nrf2: nuclear factor -erythroid 2- related factor 2; ROS: reactive oxygen species. Created with BioRender.com (accessed on 16 September 2022).